Phosphotyrosine mediated protein interactions of the discoidin domain receptor 1

Simone Lemeer1, Andrej Bluwstein, Zhixiang Wu

  • 1Chair of Proteomics and Bioanalytics, Technische Universität München, Emil Erlenmeyer Forum 5, 85354 Freising, Germany.

Journal of Proteomics
|November 8, 2011
PubMed

Insights

Discovering DDR1 signaling pathways is key for cancer and fibrosis therapies. This study maps protein interactions, revealing new targets for drug development against DDR1 receptor tyrosine kinase.

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Proteomics

Background:

  • The receptor tyrosine kinase DDR1 is linked to human cancers and fibrosis.
  • DDR1 is a therapeutic target, evidenced by its targeting by Gleevec.
  • DDR1 signaling pathway requires further investigation for therapeutic development.

Purpose of the Study:

  • To investigate DDR1 proximal signaling.
  • To identify DDR1 protein-protein interactions using proteomic approaches.
  • To map phosphotyrosine-mediated interactors of DDR1.

Main Methods:

  • Proteomic analysis of protein-protein interactions.
  • Identification and localization of DDR1 interactors.
  • Mass spectrometry for understanding genome regulation.

Main Results:

  • All known DDR1 interactors were identified and localized to specific phosphotyrosine residues.
  • Numerous new signaling proteins, including RasGAP, SHIP1, SHIP2, STATs, PI3K, and SRC family kinases, were identified as putative interactors.
  • Interaction sites were mapped to specific phosphotyrosine residues on the DDR1 receptor.

Conclusions:

  • The study provides a comprehensive map of DDR1 phosphotyrosine-mediated interactors.
  • This map serves as a foundation for functional studies on DDR1 in health and disease.
  • The identified proteins are involved in early signaling events downstream of DDR1.

Related Concept Videos

Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...